Phio Pharmaceuticals Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$1.03

+0.04 (+4.06%)

As of Jun 30, 10:53 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,081.5% upside

Low Target $25.28

Average Target $32.61

High Target $46.79

Current Price $1.03

Current
$1.03

Target
$32.61

$25.28 $32.61 avg $46.79

Scenario Analysis

Bear Case

$25.28

2,366.3%

Low target

Base Case

$32.61

+3,081.5%

Avg target

Bull Case

$46.79

+4,464.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$4.19

-75.5% from high

52-Week Low

$0.81

+26.1% from low

Target vs 52W High

$32.61

+678.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%